Australia's largest stock trading and investment forum Australia's #1 stock forum

NEURIZON THERAPEUTICS LIMITED

3.13%

15.5¢

Market Cap $76.30M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NUZ ADVANCES NUZ-001 & GLOBAL LICENSING AGREEMENT

Latest Threads

Tag

Subject

Ann: Neurizon Submits Clinical Hold Complete Response to FDA

2

21:03

107

30K

21:03

Last post Captain Goodvybes

107

30K

Ann: Appendix 4C & Quarterly Update

08/08/25

26

6.2K

08/08/25

Last post Captain Goodvybes

26

6.2K

Time to consider a "Covid" revisit?

08/08/25

12

2.4K

08/08/25

Last post Captain Goodvybes

12

2.4K

NUZ -- New Investor thread

31 32 33

06/08/25

1.9K

628K

06/08/25

Last post Paralogical

1.9K

628K

NUZ TOP HOLDERS AS AT 31 JULY 2025

06/08/25

16

3.3K

06/08/25

Last post balzams

16

3.3K

Ann: AGM Date & Director Nominations Closing Date for AGM

06/08/25

20

4.1K

06/08/25

Last post Bigunks

20

4.1K

Top 100 NUZOA holders as at 31 July 2025

05/08/25

1

497

05/08/25

Last post Dryasachip

1

497

NUZ Charting Thread

2

05/08/25

68

21K

05/08/25

Last post TheBrownHornet

68

21K

Ann: NUZ-001 Shows Promise in a Model of Huntington's Disease

2

02/08/25

77

24K

02/08/25

Last post Quiltman

77

24K

Ann: Neurizon Secures Loan Against 2025 R&D Tax Rebate

01/08/25

35

9.2K

01/08/25

Last post TheBrownHornet

35

9.2K

Neurizon inks $1.5M loan against R&D Tax Rebate

30/07/25

0

282

30/07/25

Last post ASX Insights

0

282

Attn KPAX and other Science People re 200+ hidden proteins that may drive Alzheimer’s

25/07/25

0

349

25/07/25

Last post Moreforme

0

349

Ann: Positive feedback from FDA on strategy to lift clinical hold

2

23/07/25

70

22K

23/07/25

Last post ThriftyClown

70

22K

NUZ Perplexity Assessments

21/07/25

57

17K

21/07/25

Last post Peeteepoo

57

17K

Ann: Neurizon Commences Initiatives to Lift Clinical Hold

2 3

18/07/25

149

45K

18/07/25

Last post Paralogical

149

45K

Ann: Neurizon Enters Global Licensing Agreement with Elanco

2 3

17/07/25

164

46K

17/07/25

Last post Buckland

164

46K

See All Discussions

Corporate Spotlight

ABOUT NEURIZON

Timeline

AGM Date & Director Nominations Closing Date for AGM
05 Aug 09:03	Share

Appendix 4C & Quarterly Update
30 Jul 09:14	Share

Neurizon Secures Loan Against 2025 R&D Tax Rebate
30 Jul 09:10	Share

Neurizon Submits Clinical Hold Complete Response to FDA
25 Jul 09:22	Share

Positive feedback from FDA on strategy to lift clinical hold
10 Jul 09:15	Share

Presentation Materials - Licensing Agreement Webinar
02 Jul 12:20	Share

Invitation to Shareholder Webinar
02 Jul 08:58	Share

Neurizon Enters Global Licensing Agreement with Elanco
02 Jul 08:49	Share

Notification regarding unquoted securities - NUZ
26 Jun 17:57	Share

Neurizon develops liquid formulation of NUZ-001
26 Jun 09:24	Share

NUZ-001 Shows Significant Blood-Brain Barrier Penetration
20 Jun 09:32	Share

Release of Securities from Escrow
16 Jun 19:12	Share

NUZ-001 Shows Promise in a Model of Huntington's Disease
16 Jun 09:32	Share

Change of Registered Office and Principal Place of Business
02 Jun 09:45	Share

Neurizon to present at Annual ALS Drug Development Summit
14 May 16:54	Share

Neurizon to present Q3 FY2025 Results
06 May 12:48	Share

Last Patient Successfully Completes Treatment in OLE Study
05 May 09:23	Share

Appendix 4C & Quarterly Update
28 Apr 09:11	Share

Notice of Quarterly Shareholder Update Webinar
24 Apr 09:28	Share

Appointment of Chief Financial Officer
22 Apr 09:28	Share

Leadership team strengthened with strategic appointments
17 Apr 09:22	Share

NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
04 Apr 12:07	Share

NUZ-001 Shows Positive Results in Human 3D Brain Model
01 Apr 09:03	Share

NUZ-001 shows promising respiratory outcome
24 Mar 09:47	Share

Neurizon Commences Initiatives to Lift Clinical Hold
17 Mar 09:22	Share

Appendix 4D - Half-year Financial Report - 31 December 2024
17 Feb 14:28	Share

Neurizon to Present Latest Results and Key Updates
17 Feb 09:27	Share

FDA Guidance on NUZ-001 IND Application
17 Feb 09:14	Share

Notice of Company Update Webinar
11 Feb 14:29	Share

Change of Director's Interest Notices x3
07 Feb 09:58	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 15.5¢		Change -0.005(3.13%)		Mkt cap ! $76.30M

Open	High	Low	Value	Volume
16.5¢	16.5¢	15.5¢	$33.85K	213.8K

Buyers (Bids)

No.	Vol.	Price($)
4	391170	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.5¢	75964	2

View Market Depth

No.	Vol.	Price($)
3	381170	0.155
5	653666	0.150
3	143141	0.140
1	10000	0.130
1	74892	0.125

Price($)	Vol.	No.
0.165	48187	1
0.170	158705	2
0.175	58302	3
0.180	104846	3
0.185	94000	3

Last trade - 16.10pm 08/08/2025 (20 minute delay)

NUZ (ASX) Chart